D89.812 Acute on chronic graft-versus-host disease

Name of the Condition

• Acute on chronic graft-versus-host disease

Summary

Acute on chronic graft-versus-host disease (aGVHD on cGVHD) is an immune-mediated complication that occurs when transplanted immune cells (graft) attack the recipient’s tissues (host) in patients with pre-existing chronic graft-versus-host disease. It typically arises after allogeneic hematopoietic stem cell transplantation, where acute manifestations develop in the context of ongoing chronic disease. The condition can affect multiple organ systems, with skin, gastrointestinal tract, and liver being the most commonly involved. Clinical features may overlap with both acute and chronic forms, requiring careful differentiation for management.

Causes

aGVHD on cGVHD is caused by donor immune cells recognizing the recipient’s tissues as foreign and mounting an immune response, often in the setting of persistent chronic inflammation. In allogeneic transplantation, this occurs when the graft contains functional T cells that react against the host’s histocompatibility antigens. The risk increases with greater HLA mismatch between donor and recipient, prior acute GVHD, and the use of peripheral blood stem cells (vs. bone marrow). Non-transplant-related cases may occur after transfusions in immunocompromised patients, where donor lymphocytes engraft and attack the host.

Risk Factors

• Allogeneic hematopoietic stem cell transplantation
• HLA mismatch between donor and recipient
• Prior episodes of acute GVHD
• Older age of the recipient
• Female donors for male recipients (due to prior pregnancies)
• Intensity of conditioning regimens
• Use of peripheral blood stem cells (vs. bone marrow)
• Pre-existing chronic graft-versus-host disease

Symptoms

Symptoms may include:

• Worsening skin rash, erythema, or ulceration
• Increased gastrointestinal symptoms (diarrhea, abdominal pain)
• Elevated liver enzymes or jaundice
• New or worsening oral mucosal changes
• Respiratory symptoms (cough, dyspnea) if lungs are involved
• Generalized fatigue or malaise

Diagnosis

Diagnosis is based on clinical presentation, history of transplantation, and exclusion of other causes. Biopsy of affected tissues (e.g., skin, liver, gastrointestinal tract) may confirm immune-mediated damage. Laboratory tests, including liver function tests and inflammatory markers, support evaluation. Imaging or endoscopic procedures may be used to assess organ involvement. Differentiation from infection or other post-transplant complications is critical.

Treatment Options

Treatment focuses on immunosuppression and symptom management. Options may include:

• Corticosteroids (e.g., prednisone)
• Additional immunosuppressants (e.g., calcineurin inhibitors, mycophenolate mofetil)
• Topical therapies for skin involvement
• Supportive care (e.g., hydration, nutritional support)
• Management of organ-specific complications (e.g., biliary obstruction, pulmonary issues)

Prognosis and Follow-Up

Prognosis varies based on organ involvement and response to treatment. Early intervention may improve outcomes, but chronic damage from prior cGVHD can complicate recovery. Regular follow-up is essential to monitor for progression, organ dysfunction, or secondary complications. Long-term management may involve tapering immunosuppression while preventing relapse.

Complications

• Organ fibrosis or scarring (e.g., liver cirrhosis, pulmonary fibrosis)
• Infection due to immunosuppression
• Malnutrition or weight loss
• Chronic pain or disability
• Secondary malignancies (rare)
• Psychological distress or reduced quality of life

Lifestyle & Prevention

• Adherence to prescribed immunosuppressive therapy
• Avoidance of infections (e.g., hand hygiene, vaccinations)
• Balanced nutrition to support immune function
• Regular monitoring of organ function
• Prompt reporting of new or worsening symptoms

When to Seek Professional Help

Seek immediate medical attention for:

• Severe skin rash, blistering, or pain
• Persistent diarrhea, vomiting, or abdominal cramping
• Jaundice or dark urine
• Shortness of breath or chest pain
• Unexplained fever or signs of infection

Tips for Medical Coders

Document the presence of acute manifestations superimposed on chronic graft-versus-host disease, including affected organ systems and clinical findings. Ensure the diagnosis is supported by clinical evaluation and, if available, biopsy results. Code D89.812 is specific to acute on chronic graft-versus-host disease and should not be used for acute or chronic GVHD alone. Verify that the timing and context align with the definition of this combined condition.